AMNEAL PHARMACEUTICALS, INC Gross Margin 2012-2026 | AMRX

Current and historical gross margin for AMNEAL PHARMACEUTICALS, INC (AMRX) over the last 10 years. The current gross profit margin for AMNEAL PHARMACEUTICALS, INC as of March 31, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
AMNEAL PHARMACEUTICALS, INC Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-03-31 $3.05B $1.18B 38.63%
2025-12-31 $3.02B $1.11B 36.87%
2025-09-30 $2.94B $1.08B 36.75%
2025-06-30 $2.85B $1.08B 37.68%
2025-03-31 $2.83B $1.04B 36.71%
2024-12-31 $2.79B $1.02B 36.54%
2024-09-30 $2.68B $0.95B 35.37%
2024-06-30 $2.60B $0.91B 35.07%
2024-03-31 $2.50B $0.88B 35.31%
2023-12-31 $2.39B $0.82B 34.29%
2023-09-30 $2.39B $0.85B 35.44%
2023-06-30 $2.31B $0.81B 34.89%
2023-03-31 $2.27B $0.79B 34.67%
2022-12-31 $2.21B $0.79B 35.47%
2022-09-30 $2.14B $0.74B 34.39%
2022-06-30 $2.12B $0.74B 34.90%
2022-03-31 $2.10B $0.75B 35.83%
2021-12-31 $2.09B $0.77B 36.72%
2021-09-30 $2.07B $0.77B 37.25%
2021-06-30 $2.06B $0.71B 34.27%
2021-03-31 $1.99B $0.64B 32.06%
2020-12-31 $1.99B $0.63B 31.51%
2020-09-30 $1.88B $0.57B 30.37%
2020-06-30 $1.74B $0.49B 28.23%
2020-03-31 $1.68B $0.45B 26.92%
2019-12-31 $1.63B $0.35B 21.65%
2019-09-30 $1.73B $0.44B 25.19%
2019-06-30 $1.83B $0.58B 31.84%
2019-03-31 $1.83B $0.65B 35.66%
2018-12-31 $1.66B $0.72B 43.05%
2018-09-30 $1.50B $0.77B 51.07%
2018-06-30 $1.28B $0.70B 54.81%
2018-03-31 $1.13B $0.65B 57.51%
2017-12-31 $1.03B $0.53B 50.97%
2017-09-30 $1.09B $0.87B 79.84%
2017-06-30 $1.06B $0.57B 53.67%
2017-03-31 $0.98B $0.52B 53.22%
2016-12-31 $1.02B $0.60B 58.68%
2016-09-30 $0.91B $0.13B 13.86%
2016-06-30 $0.90B $0.39B 42.68%
2016-03-31 $0.94B $0.40B 42.10%
2015-12-31 $0.86B $0.35B 41.05%
2015-09-30 $0.71B $0.30B 42.17%
2015-06-30 $0.65B $0.29B 44.74%
2015-03-31 $0.62B $0.31B 50.65%
2014-12-31 $0.60B $0.31B 52.52%
2014-09-30 $0.57B $0.29B 50.53%
2014-06-30 $0.54B $0.25B 46.21%
2014-03-31 $0.48B $0.20B 41.20%
2013-12-31 $0.51B $0.20B 38.87%
2013-09-30 $0.55B $0.23B 41.49%
2013-06-30 $0.57B $0.26B 45.84%
2013-03-31 $0.60B $0.28B 46.26%
2012-12-31 $0.58B $0.28B 48.63%
2012-09-30 $0.60B $0.30B 49.33%
2012-06-30 $0.57B $0.28B 48.95%
2012-03-31 $0.53B $0.26B 49.25%
2011-12-31 $0.51B $0.26B 50.39%
2011-09-30 $0.45B $0.23B 51.10%
2011-06-30 $0.64B $0.33B 51.72%
2011-03-31 $0.67B $0.35B 53.23%
2010-12-31 $0.88B $0.54B 61.32%
2010-09-30 $0.96B $0.58B 60.25%
2010-06-30 $0.72B $0.45B 63.04%
2010-03-31 $0.62B $0.40B 64.15%
2009-12-31 $0.36B $0.19B 52.51%
2009-09-30 $0.23B $0.12B 52.86%
2009-06-30 $0.20B $0.10B 48.74%
2009-03-31 $0.22B $0.12B 56.36%
2008-12-31 $0.21B $0.12B 55.92%
2008-09-30 $0.20B $0.11B 56.85%
2008-06-30 $0.19B $0.11B 57.59%
2008-03-31 $0.15B $0.07B 47.68%
2004-09-30 $0.12B $0.05B 41.53%
2004-06-30 $0.10B $0.04B 38.83%
2004-03-31 $0.09B $0.03B 38.37%
2003-12-31 $0.06B $0.02B 27.59%
2003-09-30 $0.05B $0.01B 28.57%
2003-06-30 $0.04B $0.01B 29.27%
2003-03-31 $0.03B $0.01B 25.00%
2002-12-31 $0.02B $0.01B 20.83%
2002-09-30 $0.02B $0.00B 11.11%
2002-06-30 $0.01B $0.00B -8.33%
2002-03-31 $0.01B $0.00B -37.50%
2001-12-31 $0.01B $0.00B -57.14%
2001-09-30 $0.01B $0.00B -66.67%
2001-06-30 $0.01B $0.00B -42.86%
2001-03-31 $0.01B $0.00B -22.22%
2000-12-31 $0.01B 0 0.00%
2000-09-30 $0.01B $0.01B 60.00%
2000-06-30 $0.01B $0.01B 70.00%
2000-03-31 $0.01B $0.01B 88.89%
1999-12-31 $0.01B $0.01B 87.50%
1999-09-30 $0.01B $0.00B 25.00%
1999-06-30 $0.01B $0.00B 16.67%
1999-03-31 $0.01B 0 0.00%
1998-12-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.945B $3.019B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00